Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Mineo

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Muscle & Nerve|September 1, 1984
A comparative study on glucagon effect between McArdle disease and Tarui diseaseI Mineo, N Kono, T Shimizu, et al.
Biochemical and Biophysical Research Communications|April 16, 1984
Decreases in hepatic fructose-2,6-bisphosphate level and fructose-6-phosphate,2-kinase activity in diabetic mice: a close relationship to the development of ketosisS Sumi, I Mineo, N Kono, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1993
[Glycogen storage disease]N Kono, T Shimizu, I Mineo, et al.
Neurology|January 1, 1995
Glucose infusion paradoxically accelerates degradation of adenine nucleotide in working muscle of patients with glycogen storage disease type VIIA Ono, M Kuwajima, N Kono, et al.
Journal of Inherited Metabolic Disease|January 1, 1984
Kinetic properties of erythrocyte phosphofructokinase in patients with type VII glycogenosis from two families--close similarity to liver type phosphofructokinaseT Shimizu, N Kono, I Mineo, et al.
Neurology|November 1, 1984
Metabolic basis of improved exercise tolerance: muscle phosphorylase deficiency after glucagon administrationN Kono, I Mineo, S Sumi, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Molecular aspect of myogenic hyperuricemia: cloning of human muscle phosphofructokinase cDNAH Nakajima, T Noguchi, I Mineo, et al.
Neurology|January 1, 1986
Increased plasma uric acid after exercise in muscle phosphofructokinase deficiencyN Kono, I Mineo, T Shimizu, et al.
Diabetes, Obesity & Metabolism|March 8, 2026
Teplizumab in Stage 2 Type 1 Diabetes: Clinical Practice Experience on Feasibility in 3 Adult PatientsV Guarnotta, F Pantò, E Vigneri, et al.
Muscle & Nerve. Supplement|January 1, 1995
A new variant case of muscle phosphofructokinase deficiency, coexisting with gastric ulcer, gouty arthritis, and increased hemolysisC Nakagawa, I Mineo, M Kaido, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Muscle & Nerve|September 1, 1984
A comparative study on glucagon effect between McArdle disease and Tarui diseaseI Mineo, N Kono, T Shimizu, et al.
Biochemical and Biophysical Research Communications|April 16, 1984
Decreases in hepatic fructose-2,6-bisphosphate level and fructose-6-phosphate,2-kinase activity in diabetic mice: a close relationship to the development of ketosisS Sumi, I Mineo, N Kono, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1993
[Glycogen storage disease]N Kono, T Shimizu, I Mineo, et al.
Neurology|January 1, 1995
Glucose infusion paradoxically accelerates degradation of adenine nucleotide in working muscle of patients with glycogen storage disease type VIIA Ono, M Kuwajima, N Kono, et al.
Journal of Inherited Metabolic Disease|January 1, 1984
Kinetic properties of erythrocyte phosphofructokinase in patients with type VII glycogenosis from two families--close similarity to liver type phosphofructokinaseT Shimizu, N Kono, I Mineo, et al.
Neurology|November 1, 1984
Metabolic basis of improved exercise tolerance: muscle phosphorylase deficiency after glucagon administrationN Kono, I Mineo, S Sumi, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Molecular aspect of myogenic hyperuricemia: cloning of human muscle phosphofructokinase cDNAH Nakajima, T Noguchi, I Mineo, et al.
Neurology|January 1, 1986
Increased plasma uric acid after exercise in muscle phosphofructokinase deficiencyN Kono, I Mineo, T Shimizu, et al.
Diabetes, Obesity & Metabolism|March 8, 2026
Teplizumab in Stage 2 Type 1 Diabetes: Clinical Practice Experience on Feasibility in 3 Adult PatientsV Guarnotta, F Pantò, E Vigneri, et al.
Muscle & Nerve. Supplement|January 1, 1995
A new variant case of muscle phosphofructokinase deficiency, coexisting with gastric ulcer, gouty arthritis, and increased hemolysisC Nakagawa, I Mineo, M Kaido, et al.
Pageof 5